Researchers engineered a compact CRISPR nuclease (CgCas12n) into a high-performance genome-editing platform, reporting a roughly 60-fold power boost in human cells. The work, published in Molecular Systems Biology, combined amino-acid substitutions with trimming of the enzyme’s RNA guide, improving editing activity while keeping the system small enough to support broader delivery and engineering options.